CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The PANOSTICS project focuses on creating a cost-effective blood test to diagnose primary aldosteronism in hypertensive patients. By implementing a new biomarker, the project aims to improve early detection and treatment options for resistant hypertension.
“PANOSTICS” comprises the validation and clinical implementation of a versatile and cost effective diagnostic blood test for the detection of primary aldosteronism (PA) among hypertensive patients.
The Aldosterone-to-Angiotensin II-Ratio (AA2-Ratio) is a mass spectrometry based diagnostic biomarker for PA.
We are planning to sell this diagnostic blood test to clinical institutions in a fee-for-service business model.
Our vision is to build up a European network of qualified fee-for-service labor…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
